Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Dying patients with rare diseases struggle to get experimental therapies

Dying patients with rare diseases struggle to get experimental therapies

Why we may never know whether the $56,000-a-year Alzheimer’s drug actually works

Why we may never know whether the $56,000-a-year Alzheimer’s drug actually works

Metabolites of intestinal bacteria can positively influence the efficacy of tumor therapies

Metabolites of intestinal bacteria can positively influence the efficacy of tumor therapies

Optical genome mapping could change the existing workflow within cytogenetic laboratories

Optical genome mapping could change the existing workflow within cytogenetic laboratories

Researchers unravel mechanisms that produce individualized metabolism in leukemia

Researchers unravel mechanisms that produce individualized metabolism in leukemia

Research team identifies a way to improve immune response during viral infections

Research team identifies a way to improve immune response during viral infections

A new study reveals unintended CRISPR/Cas9 editing events

A new study reveals unintended CRISPR/Cas9 editing events

Researchers reveal a promising target for designing anti-cancer therapies

Researchers reveal a promising target for designing anti-cancer therapies

FDA approves alternative component of chemotherapy regimen to treat acute lymphoblastic leukemia

FDA approves alternative component of chemotherapy regimen to treat acute lymphoblastic leukemia

Two CU Cancer Center studies provide insights into the link between inflammation and leukemia

Two CU Cancer Center studies provide insights into the link between inflammation and leukemia

Study maps potential link between oil and gas production and childhood leukemia risk

Study maps potential link between oil and gas production and childhood leukemia risk

Maternal Omega 3-rich diet may reduce onset of breast cancer in offspring

Maternal Omega 3-rich diet may reduce onset of breast cancer in offspring

Could microalgae-derived antiviral compounds combat SARS-CoV-2 and other viruses?

Could microalgae-derived antiviral compounds combat SARS-CoV-2 and other viruses?

New risk score system to accurately predict leukemia relapse

New risk score system to accurately predict leukemia relapse

Researchers uncover new function of regulator protein in multiple myeloma development

Researchers uncover new function of regulator protein in multiple myeloma development

Researchers unravel new mechanism that enables cancer development

Researchers unravel new mechanism that enables cancer development

Three CU researchers recognized for contributions to immunotherapy in childhood cancer

Three CU researchers recognized for contributions to immunotherapy in childhood cancer

Researchers develop new therapeutic approach for treating acute myeloid leukemia

Researchers develop new therapeutic approach for treating acute myeloid leukemia

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

New research uncovers substantial differences in rates of childhood cancers

New research uncovers substantial differences in rates of childhood cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.